Skip to main content
Back

Chapter 20: Infectious Diseases Manifesting in the Nervous System – Structure, Defenses, and Major Pathogens

Study Guide - Smart Notes

Tailored notes based on your materials, expanded with key definitions, examples, and context.

20.1 The Nervous System, Its Defenses, and Normal Biota

Overview of the Nervous System

The nervous system is divided into two main components, each with distinct anatomical and functional roles. Understanding these divisions is essential for appreciating how infectious diseases can impact neural tissues.

  • Central Nervous System (CNS): Composed of the brain and spinal cord, responsible for processing and integrating information.

  • Peripheral Nervous System (PNS): Consists of nerves emanating from the CNS to sense organs and peripheral tissues.

Functions of the Nervous System

  • Sensory: Sensory receptors at peripheral nerve endings generate impulses transmitted to the CNS.

  • Integrative: The CNS translates impulses into sensations or thoughts and drives motor functions.

  • Motor: Involves activation of muscles and glands.

Protective Structures and Fluids

  • Bone: The brain is encased in the skull; the spinal cord is protected by the vertebral column.

  • Meninges: Three protective membranes surrounding the CNS: dura mater, arachnoid mater, and pia mater.

  • Cerebrospinal Fluid (CSF): Fills the subarachnoid space, provides nutrition, and acts as a cushion for the brain and spinal cord.

Defenses of the Nervous System

  • Bony casings: Protect against traumatic injury.

  • CSF: Serves as a shock absorber.

  • Blood–Brain Barrier: Specialized endothelial cells restrict passage of most molecules and microbes into the CNS, making infections rare but also complicating drug delivery.

Specialized Immune Cells

  • Microglial cells: CNS-resident phagocytes.

  • Brain macrophages: Present but less active than peripheral phagocytes.

Nervous System

Defenses

Normal Biota

CNS & PNS

Bony structures, blood–brain barrier, microglial cells, macrophages

None

Normal Biota and the Gut–Brain Axis

  • The CNS and PNS are considered sterile; detection of microbes indicates pathology.

  • Emerging evidence suggests the gut microbiome may influence CNS function and autoimmunity (the gut–brain axis).

20.2 Infectious Diseases Manifesting in the Nervous System

Overview of Meningitis

Meningitis is inflammation of the meninges, most often caused by bacteria, but also by viruses and fungi. Rapid diagnosis and treatment are critical due to the risk of severe neurological damage or death.

  • Symptoms: Fever, headache, stiff neck, nausea, vomiting, photophobia, seizures, altered mental status.

  • Pathogenesis: Virulence factors enable pathogens to penetrate the blood–brain barrier.

Major Bacterial Causes of Meningitis

  • Neisseria meningitidis: Gram-negative diplococcus, significant cause of epidemic meningitis. Virulence factors include capsule, endotoxin, and IgA protease. Diagnosed by Gram stain, culture, and oxidase test.

  • Streptococcus pneumoniae: Gram-positive, encapsulated coccus, leading cause of community-acquired meningitis. Produces alpha-hemolysin and hydrogen peroxide. Two vaccines available.

  • Haemophilus influenzae (type b): Gram-negative coccobacillus, historically a major cause, now rare due to vaccination.

  • Listeria monocytogenes: Gram-positive rod, grows in cold, heat, salt, and bile; can cross placenta, causing fetal death. Associated with contaminated dairy, poultry, and meat.

Major Fungal Causes of Meningitis

  • Cryptococcus neoformans: Encapsulated yeast, causes chronic meningitis, especially in immunocompromised patients. Transmitted via bird droppings.

  • Coccidioides spp.: Dimorphic fungus ("Valley Fever"), endemic in the Americas. Forms spherules in tissue; inhalation of spores is the main route.

Viral Meningitis

  • Accounts for the majority of meningitis cases ("aseptic meningitis").

  • Most common in children; 90% caused by enteroviruses.

  • Generally milder than bacterial or fungal forms; resolves in about two weeks.

Meningitis Disease Table

Causative Organism(s)

Most Common Modes of Transmission

Virulence Factors

Culture/Diagnosis

Prevention

Treatment

Distinctive Features

Epidemiological Features

Neisseria meningitidis

Droplet contact

Capsule, endotoxin, IgA protease

Gram stain/culture of CSF, blood, rapid antigen tests

Conjugated vaccine, prophylactic antibiotics

Penicillin G, ceftriaxone

Petechiae, rapid decline

Highest incidence in children/young adults

Streptococcus pneumoniae

Droplet contact

Capsule, alpha-hemolysin, hydrogen peroxide

Gram stain/culture of CSF

Two vaccines (Prevnar, Pneumovax)

Ceftriaxone, vancomycin

No petechiae, underlying susceptibility

Most common in adults

Haemophilus influenzae

Droplet contact

Capsule

Cultured on chocolate agar

Hib vaccine

Ceftriaxone

Severe, rapid onset

Rare in vaccinated populations

Listeria monocytogenes

Vehicle (food)

Intracellular growth

Cold enrichment, rapid methods

Cooking food, avoiding unpasteurized dairy

Ampicillin, gentamicin

Asymptomatic in healthy adults

High mortality in neonates, elderly

Cryptococcus neoformans

Vehicle (air, dust)

Capsule, melanin production

Negative staining, biochemical tests

N/A

Amphotericin B, flucytosine

Chronic, common in AIDS patients

90% of infections in HIV+ patients

Coccidioides spp.

Vehicle (air, dust, soil)

Granuloma (spherule) formation

Identification of spherules, Sabouraud's agar

Avoiding airborne exposure

Fluconazole, amphotericin B

Endemic regions only

200–300 cases/year in endemic areas

Viruses

Droplet contact

Lytic infection of host cells

Viral culture, antigen tests

N/A

Supportive care

Milder than bacterial/fungal

26,000–42,000 hospitalizations/year in US

Neonatal and Infant Meningitis

  • Usually transmitted from mother to infant during birth or in utero.

  • Most common causes: Streptococcus agalactiae (Group B strep), Escherichia coli (K1 strain), and Listeria monocytogenes.

  • Premature infants are at higher risk; mortality rates have declined but morbidity remains significant.

Causative Organism(s)

Most Common Modes of Transmission

Virulence Factors

Culture/Diagnosis

Prevention

Treatment

Distinctive Features

Epidemiological Features

Streptococcus agalactiae

Vertical (during birth)

Capsule

Culture mother’s genital tract, CSF culture of infant

Chemoprophylaxis of mother

Penicillin G plus aminoglycosides

Most common; positive culture of mother confirms diagnosis

Colonizes 10–30% of women

Escherichia coli (K1)

Vertical (during birth)

Capsule

CSF Gram stain/culture

N/A

Cefotaxime or combination therapy

Suspected if infant is premature

20% mortality in premature infants

Listeria monocytogenes

Vertical

Intracellular growth

Cold enrichment, rapid methods

Cooking food, avoiding unpasteurized dairy

Ampicillin, gentamicin

Asymptomatic in healthy adults

High mortality in neonates

Meningoencephalitis

  • Definition: Inflammation of both the brain and meninges.

  • Causative agents: Amoebas such as Naegleria fowleri (primary amoebic meningoencephalitis) and Acanthamoeba (granulomatous amoebic meningoencephalitis).

Causative Organism(s)

Most Common Modes of Transmission

Virulence Factors

Culture/Diagnosis

Prevention

Treatment

Epidemiological Features

Naegleria fowleri

Vehicle (exposure to warm freshwater)

Invasiveness

CSF exam, brain imaging, biopsy

Avoid swimming in warm, untreated water

Pentamidine, sulfadiazine

Rare, almost always fatal

Acanthamoeba

Direct contact

Invasiveness

CSF exam, brain imaging, biopsy

N/A

Surgical excision, pentamidine

Immunocompromised patients

Pearson Logo

Study Prep